Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materialsmethods, and suitablebiochemical and physicochemicalfactors to restore, maintain, improve, or replace different types of biological tissues
Three general components are involved in tissue engineering: (1) reparative cells that can form afunctional matrix; (2) an appropriate scaffold for transplantation and support; and (3) bio-reactive molecules, such as cytokines and growthfactors that will support and choreograph the formation of the desiredtissue.
Steps to prepare artificial tissue:
1) BIOPSY (donor-tissueextraction) - eitherfromfluidtissuelikebloodusingcentrifugationorapheresis (easier process) or from solid tissue that involves more steps.
2) CELLISOLATIONandCULTIVATION (manipulation with cells) – it is safest to use autologous cells (primarycells extracted from the same person's own healthytissues to which the artificialtissue will be transplanted),
recently there has been trend to use mesenchymal stem cells from bone marrow that can differentiate into various tissue types. Other types of cells that can be used are allogenic (donor from the same species), heterologous (or xenogenic, donor is different species). In those cases, rejection of the host's immune system and possible disease transmission are risks that need to be considered.
3) SCAFFOLDS, seeding, cultivation – implantation or 'seeding' of cells into artificialstructure that can support 3-Dtissue formation; that resemble the extracellular matrix
4) IMPLANTATION - (implantationintolivingbody)
5) DETECTION - (property analysis)
In vivo delivery
In vivo gene therapy refers to directdelivery of genetic material either intravenously (throughanIV) or locally to a specificorgan (eg, directly into the eye)
Ex vivo delivery
Ex vivo genetherapy refers to the process of removingspecificcells from a person, genetically altering them in a laboratory, and then transplanting them back into the person.